Pfizer - the price riser.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Works matching IS 09596682 AND DT 2016 AND VI 27 AND IP 12
Results: 9
1
2
More clarity needed on the true benefits and risks of statins.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 15, doi. 10.1002/psb.1519
- By:
- Publication type:
- Article
3
Advances in the prevention and treatment of dementia.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 18, doi. 10.1002/psb.1520
- By:
- Publication type:
- Article
4
SGLT2 inhibitors and risk of genitourinary infections.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 26, doi. 10.1002/psb.1521
- By:
- Publication type:
- Article
5
Recommended management of thyroid disorders.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 31, doi. 10.1002/psb.1522
- By:
- Publication type:
- Article
6
NICE multimorbidity guideline: coping with complexity in care.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 40, doi. 10.1002/psb.1523
- By:
- Publication type:
- Article
7
Duavive HRT: conjugated oestrogens with bazedoxifene.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 53, doi. 10.1002/psb.1525
- By:
- Publication type:
- Article
8
Religious constraints on prescribing medication.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 47, doi. 10.1002/psb.1524
- By:
- Publication type:
- Article
9
New from Nice.
- Published in:
- Prescriber, 2016, v. 27, n. 12, p. 54, doi. 10.1002/psb.1526
- Publication type:
- Article